Article
[How i treat a patient with idiopathic pulmonary fibrosis].
Revue medicale de Liege - 1 Sept 2017
Guiot J, Duysinx B, Bonhomme O, Louis R, Corhay J-L
Abstract excerpt
Idiopathic pulmonary fibrosis (IPF) is a rare disorder of unknown origin, which is associated with a high mortality and whose incidence has been increasing for several years. Nowadays there are two anti-fibrotic therapies (pirfenidone - nintedanib) known to reduce significantly the decline in respiratory function tests of patients suffering from this condition. The only curative therapeutic option remains the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
